MYCML

WIPO WIPO 2015

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke MYCML wurde als Wortmarke am 04.02.2015 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 18. Mai 2021

Markenform Wortmarke
Aktenzeichen 1256582
Länder Schweiz China Europäische Gemeinschaft Japan Südkorea
Basismarke US Nr. 86360598, 07. August 2014
Anmeldedatum 04. Februar 2015
Ablaufdatum 09. April 2018

Markeninhaber

10222 Barnes Canyon Road,
Building 1
US

Markenvertreter

2040 Main Street, 14th Floor Irvine CA 92614 US

Waren und Dienstleistungen

01 Reagents for scientific and research use, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for research, clinical research, and laboratory research use
05 Assays for the treatment or diagnosis of disease; medical diagnostic reagents, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic kits comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatment, monitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids
42 DNA analysis services for scientific research purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays
44 DNA screening for medical purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
16. Oktober 2018 2018/45 Gaz US RAW: Total Ceasing Effect
12. Dezember 2016 2017/11 Gaz CH Ablehnung
16. Juni 2016 2016/27 Gaz CH Ablehnung
07. Juni 2016 2016/24 Gaz KR Ablehnung
25. Mai 2016 2016/22 Gaz EM Ablehnung
16. Mai 2016 2016/21 Gaz CN Ablehnung
14. Januar 2016 2016/3 Gaz JP Ablehnung
06. Januar 2016 2016/2 Gaz KR Ablehnung
04. Februar 2015 2015/28 Gaz US Eintragung

ID: 141256582